tubulazole has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Brabander, M; Heeres, J; van Ginckel, R; Vanherck, W | 1 |
| De Brabander, MJ; Dragonetti, CH; Geuens, GM; Goossens, F; Mareel, MM; Nuydens, RM; Van de Veire, RM; Willebrords, RE | 1 |
2 other study(ies) available for tubulazole and Leukemia L 1210
| Article | Year |
|---|---|
The effects of tubulazole, a new synthetic microtubule inhibitor on experimental neoplasms.
Topics: Animals; Cyclophosphamide; Dioxolanes; Dioxoles; Leukemia L1210; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Sarcoma, Experimental; Vincristine | 1984 |
Effects of tubulozole on the microtubule system of cells in culture and in vivo.
Topics: Animals; Cell Division; Cells, Cultured; Chickens; Dioxolanes; Dioxoles; Dipodomys; Female; Humans; Leukemia L1210; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Microscopy, Electron; Microtubules; Myocardium; Polymers; Pregnancy; Tubulin | 1985 |